Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer
- Authors:
- Xiaobin Wang
- Huihan Wang
- Renge Bu
- Xiang Fei
- Chenghai Zhao
- Yongsheng Song
View Affiliations
Affiliations: Department of Urology, Shengjing Hospital affiliated to China Medical University, Shenyang 110004, P.R. China, Department of Hematology Shengjing Hospital affiliated to China Medical University, Shenyang 110004, P.R. China, Department of Pathophysiology, Shengjing Hospital affiliated to China Medical University, Shenyang 110004, P.R. China
- Published online on: May 11, 2012 https://doi.org/10.3892/ol.2012.713
-
Pages:
334-338
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The aims of this study were to determine the methylation and expression status of secreted Frizzled-related protein 1 (SFRP1) in bladder cancer, to explore the mechanisms involved and to study the role of SFRP1 in the pathogenesis of bladder cancer. SFRP1 mRNA was detected by reverse transcription PCR (RT-PCR). The DNA methylation status was determined by methylation-specific PCR and protein was detected using western blotting. The results of the present study demonstrated that SFRP1 was methylated in the bladder cancer cell lines T24 and 5637, but not in SCaBER cells. After treating T24 and 5637 cells with a demethylating agent, the cells expressed SFRP1 mRNA and protein. Among the 45 patients with bladder cancer, methylation of SFRP1 was detected in 28 patients (62.2%). Of the matched cancer-adjacent tissues, 6 (13.3%) were found to have methylated SFRP1. The result is statistically significant (P<0.01). In conclusion, SFRP1 is downregulated in certain bladder cancer patients as a consequence of methylation. SFRP1 methylation may be involved in the pathogenesis of bladder cancer via excessive activation of the Wnt signaling pathway.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
 |
Figure 7
|
 |
Figure 8
|
View References
|
1
|
Katanaev VL: The Wnt/Frizzled GPCR
signaling pathway. Biochemistry (Mosc). 75:1428–1434. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Esteve P and Bovolenta P: The advantages
and disadvantages of sfrp1 and sfrp2 expression in pathological
events. Tohoku J Exp Med. 221:11–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zou H, Molina JR, Harrington JJ, et al:
Aberrant methylation of secreted frizzled-related protein genes in
esophageal adenocarcinoma and Barrett’s esophagus. Int J Cancer.
116:584–591. 2005.PubMed/NCBI
|
|
4
|
Lodygin D, Epanchintsev A, Menssen A,
Diebold J and Hermeking H: Functional epigenomics identifies genes
frequently silenced in prostate cancer. Cancer Res. 65:4218–4227.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bui TD, O’Brien T, Crew J, Cranston D and
Harris AL: High expression of Wnt7b in human superficial bladder
cancer vs invasive bladder cancer. Br J Cancer. 77:319–324. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuang L, Zhang Z and Guo Y: Aberrant
expression of growth factor Wnt-5A in six urinary malignant cell
lines. Chin Med J (Engl). 112:251–255. 1999.PubMed/NCBI
|
|
7
|
Urakami S, Shiina H, Enokida H, et al:
Epigenetic inactivation of Wnt inhibitory factor-1 plays an
important role in bladder cancer through aberrant canonical
Wnt/beta-catenin signaling pathway. Clin Cancer Res. 12:383–391.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tycko B: Cancer epigenetics and targeted
therapies. Oncology (Williston Park) 25. 228:2312011.PubMed/NCBI
|
|
9
|
Ezan J, Leroux L, Barandon L, et al:
FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway,
controls vascular cell proliferation in vitro and in vivo.
Cardiovasc Res. 63:731–738. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Häusler KD, Horwood NJ, Chuman Y, et al:
Secreted frizzled-related protein-1 inhibits RANKL-dependent
osteoclast formation. J Bone Miner Res. 19:1873–1881.
2004.PubMed/NCBI
|
|
11
|
Bodine PV, Zhao W, Kharode YP, et al: The
Wnt antagonist secreted frizzled-related protein-1 is a negative
regulator of trabecular bone formation in adult mice. Mol
Endocrinol. 18:1222–1237. 2004. View Article : Google Scholar : PubMed/NCBI
|
